BioSpace News Archive

Business

Maryland’s Life Sciences Scene Boasts Strong R&D, Manufacturing Talent

The Washington, D.C.–Baltimore area ranks in the top six for life sciences R&D and manufacturing talent, according to a CBRE report. The Maryland Department of Commerce’s director of life sciences discusses the workforce and how the state is adapting to changing needs.

July 24, 2025

·

4 min read

·

Angela Gabriel

Accumulated problems, contradictions. Dead end, we need to go back. You cannot continue further. Complete impossibility to continue. Rejection of an idea. Hard sanctions. Fatal error.

Obesity

Roche Drops Early Obesity Asset, Citing Lack of Competitiveness

Roche obtained CT-173, a PYY mimetic, in its $2.7 billion acquisition of Carmot Therapeutics in December 2023. The company reported the change in its second quarter earnings call.

July 24, 2025

·

2 min read

·

Tristan Manalac

Illustration of employer’s hand holding employee who was laid off to drop him out of office

Layoffs

Genentech Downsizes by 87 as Priorities Shift

The latest round of terminations, which will take effect Sept. 15, comes after Genentech fired more than 500 employees in the last 15 months.

July 24, 2025

·

2 min read

·

Tristan Manalac

Chalk drawing arrow turn or break through road block traffic pylon on dark blackboard using as obstacle, solution for business problem or break through to success concept.

Antibody-drug conjugate (ADC)

GSK’s Comeback for Blenrep on Pause as FDA Delays Decision

The new target action date for Blenrep, which GSK is proposing for the second-line treatment of relapsed or refractory multiple myeloma, is Oct. 23.

July 24, 2025

·

2 min read

·

Tristan Manalac

Illustration showing businesswoman surprised by lost connection

Layoffs

Tales of the Weird: How Some Biopharma Employees Found Out About Layoffs

Companies sometimes miss the mark when it comes to telling employees they’re out of a job. From accidental goodbyes to surprise meetings, there are many strange ways biopharma professionals have learned about layoffs.

July 24, 2025

·

4 min read

·

Angela Gabriel

Cairo, Egypt, October 31 2024: Novartis CO building in Egypt, Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland, manufactures the drugs

I&I

Novartis Drops up to $1B+ for Drug Discovery Deal With Matchpoint

The partnership with Matchpoint Therapeutics gets Novartis global rights on all molecules for several unannounced inflammatory diseases identified through the biotech’s discovery platform.

July 24, 2025

·

2 min read

·

Dan Samorodnitsky

Facade of AstraZeneca's office in Shanghai, China

Autoimmune disease

AstraZeneca’s Claims PIII Win With Nanobody Treatment for Myasthenia Gravis

The company didn’t share specific data for the molecule, gefurulimab, but said it hit all endpoints in the Phase III PREVAIL trial and promised to share more at an upcoming scientific meeting.

July 24, 2025

·

2 min read

·

Dan Samorodnitsky